The potential of shame as a message appeal in antismoking television advertisements

Amonini, Claudia; Pettigrew, Simone; Clayforth, Cassandra

doi:10.1136/tobaccocontrol-2014-051737

Cited by 30 publications

(22 citation statements)

References 21 publications

(37 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Davidoff too considers that the effect of shame is negative and compromises efforts to improve care 57. In contrast, a smaller number of writers58 have suggested that shame has moral purpose, particularly in the context of prompting social and political action, global advocacy59 and public health 60. One study suggests that those who experience and can acknowledge feelings of shame may eventually go on to perform better in a specific clinical task 61…”

Section: Shame Identity and Professional Survivalmentioning

confidence: 99%

Vulnerability, survival and shame in Nina Raine’sTiger Country

Bowman

2017

Med Humanities

View full text Add to dashboard Cite

Shame in healthcare remains relatively underexplored, yet it is commonplace and its impact is significant. This paper explores shame in healthcare using Nina Raine's 2011 play Three manifestations of shame are explored, namely (1) shame in relation to professional identity and survival in the clinical workplace; (2) shame and illness as experienced by both patients and doctors; and (3) the systemic and organisational influences on shame within healthcare systems. I suggest that the theatre is particularly well-placed to elucidate shame, and that demonstrates the prevalence and impact of shame on clinical work. Shame has a fundamental and overlooked relationship with damaging and well-documented phenomena in healthcare, including moral distress, ethical erosion, compassion fatigue, burnout, stress and ill health. Attention to shame is essential for those interested in medicine and healthcare and must, I propose, include the experiences and perceptions of those who provide care, as well as attending to those who receive care.

show abstract

Section: Shame Identity and Professional Survivalmentioning

confidence: 99%

Vulnerability, survival and shame in Nina Raine’sTiger Country

Bowman

2017

Med Humanities

View full text Add to dashboard Cite

show abstract

“…Amonini, Pettigrew, & Clayforth, 2015). In addition, we know little about whether, and how, Australian policy level changes, which are among the most comprehensive globally (Scollo & Winstanley, 2015), contribute to smokers' perceptions of, and responses to, stigma.…”

Section: Smoking-related Stigmamentioning

confidence: 99%

Differential access to health care and support? A qualitative analysis of how Australian smokers conceptualise and respond to stigma

Wigginton

Morphett

Gartner

2016

Critical Public Health

View full text Add to dashboard Cite

Scholarship on stigma, originally theorised as a 'mark' of social disgrace or difference, has since moved away from individual-level analyses to consider the socio-cultural context in the 'marking' of groups of people. In response to this theoretical shift, scholars have demonstrated how extensive tobacco denormalisation policies have contributed to the stigmatisation of smokers, documenting smokers' experiences of stigma across a number of developed countries.We extend this analysis to the Australian context, examining smokers' constructions of stigma and their reactions to policies that would give smokers differential access to healthcare. Based on 29 interviews with Australian smokers, we focus on what constitutes evidence of stigma and how participants' use social comparisons to respond to stigma. We then explore an assumption underpinning participants' accounts of stigma: that only smokers committed to cessation are 'deserving' of treatment. We close by discussing theoretical perspectives and opportunities in stigma research and the need to extend a stigma lens to study emerging public health issues, such as electronic cigarettes.

show abstract

“…This entails a moral responsibility for individuals to identify the disease risk factors relevant to them and to work towards addressing them. If they do not, then they may be subjected to stigma or public shaming (Amonini et al, 2015;Lupton, 2014). The findings reported in this chapter show that "the individual" is the central locus in lay understandings of smoking amongst smokers.…”

Section: Discussionmentioning

confidence: 99%

“…One potential benefit of medicalisation is that defining a problem as a medical issue may reduce stigma due to the implication that afflicted individuals do not have full control over it. This is a particularly pertinent issue for drug addiction, and increasingly relevant to smoking tobacco, where the stigmatisation of smokers is a controversial strategy employed to reduce smoking rates (Amonini, Pettigrew, & Clayforth, 2015;Bell, Salmon, Bowers, Bell, & McCullough, 2010;Brown-Johnson & Prochaska, 2015). The adoption of a "sick role" might reduce feelings of self-blame by lessening an individual's sense of responsibility, and could increase treatment seeking.…”

Section: Medicalisation: a Brief Backgroundmentioning

confidence: 99%

“…The individual is judged morally responsible for illnesses that are deemed preventable (Lupton, 1993). As smoking is a key risk factor for many serious diseases, there is significant moralising around cigarette smoking, to the point where advertisements shaming smokers have been recommended as a strategy to encourage quit attempts (Amonini et al, 2015). For those interviewed for this study, this focus on individual responsibility was central to narratives about smoking cessation.…”

Section: Concluding Remarks On Chaptermentioning

confidence: 99%

See 1 more Smart Citation

The biomedicalisation of smoking cessation: a mixed methods study of lay perspectives on nicotine addiction

Morphett¹

View full text Add to dashboard Cite

Biomedical models of addiction are becoming increasingly prevalent in public discourse about cigarette smoking, however there is some concern that smoking is becoming overly medicalised. Neuroscience research has revealed that nicotine use is associated with longlasting changes in the brain, and these findings are being presented in the media and in advertising campaigns for smoking cessation pharmacotherapies. The "brain disease model of addiction", which posits that chronic drug use leads to long-term changes in brain networks that make it very difficult to quit, is increasingly being applied to tobacco dependence. This is controversial in the tobacco control field, where population-based strategies have been successful in reducing the prevalence of smoking. Proponents of a biomedical model of tobacco dependence believe that it will lead to increased treatment seeking, more efficacious treatments, and a reduction in stigma. Critics of a biomedical model of nicotine addiction have expressed concerns that it will reduce individual responsibility for smoking, increase stigma, and undermine individuals' beliefs in their ability to quit. While these competing views on the impacts of biomedical models of addiction have been debated in the academic literature, it is unknown to what extent members of the public endorse a biomedical model of tobacco dependence, and have incorporated it into their everyday understandings of smoking.This research examined the influence of biomedical discourses of smoking on lay beliefs of Australian smokers and non-smokers about tobacco dependence and its treatment. It also explored daily smokers' attitudes to the labelling of nicotine addiction as a "brain disease." A mixed methods approach was used to ascertain the extent to which biomedical understandings of smoking have been incorporated into lay discourse on smoking and quitting; how Australian smokers understand nicotine addiction and the role of the brain; and how endorsement of the brain disease model of addiction may be related to smokers' attitudes towards smoking cessation and preferences for quitting methods.The thesis is comprised of three studies. Firstly, a secondary analysis of data from interviews with 55 members of the general public, including never smokers, ex-smokers and current smokers. The data was analysed to ascertain public attitudes on the best methods for quitting smoking. Results revealed that while cessation medications were frequently described as a helpful means to quit, the role of willpower, choice, and motivation were seen as central.iii Medications were often described as a "second line of defence", or as aids to be used alongside counselling or behavioural strategies.A second qualitative study involved in-depth interviews with 29 daily smokers about their views on smoking cessation and their understanding of the role of the brain in smoking. The results revealed positive attitudes to quitting without assistance. Cessation medications were not perceived as magic bullets, and willpower and perso...

show abstract

The potential of shame as a message appeal in antismoking television advertisements

Cited by 30 publications

References 21 publications

Vulnerability, survival and shame in Nina Raine’sTiger Country

Vulnerability, survival and shame in Nina Raine’sTiger Country

Differential access to health care and support? A qualitative analysis of how Australian smokers conceptualise and respond to stigma

The biomedicalisation of smoking cessation: a mixed methods study of lay perspectives on nicotine addiction

Contact Info

Product

Resources

About